Evidence map›Paper›PMID 25893484›Full record

ArticleBiomedical microdevices2015

Simple microfluidic device for studying chemotaxis in response to dual gradients.

S F Moussavi-Harami, H M Pezzi, A Huttenlocher, D J Beebe

Abstract read
In one paragraph

Article in Biomedical microdevices, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Aerosol Jet Printing in Biotechnologies.Bioengineering (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Microfluidic devices for neutrophil chemotaxis studies.Journal of translational medicine · 2020
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

S F Moussavi-HaramiDepartment of Biomedical Engineering, University of Wisconsin, Madison, WI, USA.
H M Pezzi
A Huttenlocher
D J Beebe

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell AnalysisR01CA181648 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BERRY, SCOTT M, LANG, JOSHUA MICHAEL · 2014 to 2018
$1.6M
Microchannel cell-based assays to enable cancer researchR33CA137673 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J · 2009 to 2011
$1.4M
NCATS NIH HHS UL1 TR000427NCATS NIH HHS UL1TR000427NCI NIH HHS 5R33CA137673NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA181648NCI NIH HHS R01 CA181648-01A1NCI NIH HHS R33 CA137673NIBIB NIH HHS R01 EB010039NIBIB NIH HHS R01EB010039NIGMS NIH HHS R01GM08148NIGMS NIH HHS T32 GM008692
6 · The paper itself

Abstract

Chemotaxis is a fundamental biological process where complex chemotactic gradients are integrated and prioritized to guide cell migration toward specific locations. To understand the mechanisms of gradient dependent cell migration, it is important to develop in vitro models that recapitulate key attributes of the chemotactic cues present in vivo. Current in vitro tools for studying cell migration are not amenable to easily study the response of neutrophils to dual gradients. Many of these systems require external pumps and complex setups to establish and maintain the gradients. Here we report a simple yet innovative microfluidic device for studying cell migration in the presence of dual chemotactic gradients through a 3-dimensional substrate. The device is tested and validated by studying the migration of the neutrophil-like cell line PLB-985 to gradients of fMLP. Furthermore, the device is expanded and used with heparinised whole blood, whereupon neutrophils were observed to migrate from whole blood towards gradients of fMLP eliminating the need for any neutrophil purification or capture steps.

Indexed as

Lab-On-A-Chip DevicesCell LineChemotactic FactorsChemotaxisDose-Response Relationship, DrugEquipment DesignEquipment Failure AnalysisFlow CytometryFlow Injection AnalysisHumansNeutrophilsN-Formylmethionine Leucyl-PhenylalanineChemotactic FactorsN-Formylmethionine Leucyl-Phenylalanine

Identifiers

PMID25893484
PMCPMC4768479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.